Healthy controls are also included to enable comparisons between patient groups and the general population. A wide range of biomaterials is collected, including blood, skin biopsies, skin scales, microbiome samples, lipids, feces, urine, nails, hair, and—for specific subgroups—tear fluid. In addition to biomaterials, clinical data and patient questionnaires are gathered, creating a comprehensive platform for future scientific research into the causes, progression, and treatment of skin diseases.
Gain deeper insight into the causes, progression, and treatment of chronic/inflammatory skin diseases in both adults and children.
Enable comparison between different patient populations and healthy controls using a broad range of biomaterials and clinical data.
Facilitate the identification of biomarkers and molecular mechanisms underlying various skin diseases.
Support the development and evaluation of targeted therapeutic strategies and personalized medicine.
Create a comprehensive resource for future scientific research and collaboration in dermatology.
The DermaLines cohort includes both adult and pediatric patients with a broad range of chronic or inflammatory skin diseases, such as eczema, psoriasis, contact allergy, and rare conditions like cutaneous lymphoma and dermatomyositis. Healthy controls of different ages are also enrolled to enable direct comparison.
Collected (meta)data include clinical information, patient questionnaires, and a wide variety of biomaterials such as blood, skin biopsies, skin scales, microbiome samples, lipids, feces, urine, nails, hair, and—for selected subgroups—tear fluid.
The DermaLines cohort can have significant societal impact by enabling the development of more effective and personalized treatments for chronic skin diseases, improving patients' quality of life and psychosocial wellbeing. Early identification of risk factors and biomarkers can lead to better prevention and faster diagnosis, reducing healthcare costs. Furthermore, the knowledge gained can foster public awareness, decrease stigma, and support better participation of patients in work and social activities.
University Medical Center Groningen (UMCG)
Dermatology department, AB21 - DermaLines
PO Box 30.001
9700 RB Groningen
The Netherlands
Visiting address
University Medical Center Groningen (UMCG)
Antonius Deusinglaan 1
9713 AV Groningen
More information visit our website.
